KR20000001522A - Charcoal capsulated or tabletted health keeping medicine - Google Patents

Charcoal capsulated or tabletted health keeping medicine Download PDF

Info

Publication number
KR20000001522A
KR20000001522A KR1019980021824A KR19980021824A KR20000001522A KR 20000001522 A KR20000001522 A KR 20000001522A KR 1019980021824 A KR1019980021824 A KR 1019980021824A KR 19980021824 A KR19980021824 A KR 19980021824A KR 20000001522 A KR20000001522 A KR 20000001522A
Authority
KR
South Korea
Prior art keywords
charcoal
capsulated
tabletted
health
health keeping
Prior art date
Application number
KR1019980021824A
Other languages
Korean (ko)
Inventor
이경미
Original Assignee
이경미
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이경미 filed Critical 이경미
Priority to KR1019980021824A priority Critical patent/KR20000001522A/en
Publication of KR20000001522A publication Critical patent/KR20000001522A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

PURPOSE: A health keeping medicine made up of capsulated or tableted charcoal is provided to perform the virulence elimination, digestion promotion, and gas elimination. CONSTITUTION: A health promoting medicine made up of capsulated or tableted charcoal comprises: coating the charcoal powder(1) with coating material(2) dissolved in human intestines to manufacture a health promoting medicine to protect the modernist from being exposed to the virulence, to reduce the swelling and cation in the body and without toxicity or side effect.

Description

숯을 캡슐화 또는 알약화한 건강증진의 약품Health Promotion Drug Encapsulated or Pilled with Charcoal

1. 발명의 목적 : 체내의 독성제거 소화촉진·가스제거 능이 있는 숯의 성질을 이용 쉽게 복용할 수 있게 해 독성물질에 늘 노출되는 현대인의 건강을 보호하며 뽕나무 숯가루의 경우는 부기 감소능이 있으므로 아침에 얼굴이 잘 붓는 사람의 경우 복용시 부기를 감소시키며1. The purpose of the invention: To remove the toxic substances in the body by using the properties of charcoal, which promotes digestion and gas removal, it can be easily taken to protect the health of modern people who are always exposed to toxic substances. People with a swollen face in the morning reduce swelling when taken

음이온을 많이 발생하는 숯의 성질을 이용 체내 양이온을 감소시키며 몸의 활력과 발란스 유지Charcoal that generates a lot of negative ions reduces cations in the body and maintains vitality and balance

또한 숯의 약품화로 중독성이나 부작용 없는 상시 복용가능한 건강증진 약품을 만듬It also makes charcoal chemicals that can be taken regularly without any addictive or side effects.

2. 발명의 구성 : 숯가루 + 사람장에서 녹는 캡슐 또는 코팅제 + 첨가물2. Composition of Invention: Charcoal powder + capsule or coating agent + additive

상기의 식별자가 없습니다.No identifier above

제 1도 : 숯가루를 사람의 장에서 녹는 캡슐에 넣어 복용이 쉽게한 경우의 단면도Figure 1: Sectional view of the case where it is easy to take charcoal powder in human intestine

1 : 바깥쪽 캡슐1: outer capsule

2 : 안쪽 캡슐2: inside capsule

3 : 숯가루 + 첨가물3: charcoal powder + additive

제 2도 : 숯가루를 사람의 장에서 녹는 코팅물질에 싸서 알약화 한 경우의 단면도FIG. 2: Sectional view of charcoal powder wrapped in a coating material that melts in the human intestine

1 : 숯가루 + 첨가물1: Charcoal Powder + Additives

2 : 코팅한 물질2: coated material

상기의 식별자가 없습니다.No identifier above

상기의 식별자가 없습니다.No identifier above

Claims (1)

위 3 발명의 상세한 설명의3 of the detailed description of the invention 발명의 목적, 발명의 구성 전부Objectives of the Invention, Structure of the Invention
KR1019980021824A 1998-06-08 1998-06-08 Charcoal capsulated or tabletted health keeping medicine KR20000001522A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019980021824A KR20000001522A (en) 1998-06-08 1998-06-08 Charcoal capsulated or tabletted health keeping medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980021824A KR20000001522A (en) 1998-06-08 1998-06-08 Charcoal capsulated or tabletted health keeping medicine

Publications (1)

Publication Number Publication Date
KR20000001522A true KR20000001522A (en) 2000-01-15

Family

ID=19539117

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980021824A KR20000001522A (en) 1998-06-08 1998-06-08 Charcoal capsulated or tabletted health keeping medicine

Country Status (1)

Country Link
KR (1) KR20000001522A (en)

Similar Documents

Publication Publication Date Title
BR0107565A (en) Replaced benzimidazole dosage forms and methods of use
IS4083A (en) Composition of pharmaceutical substances, method of manufacture thereof, and use as pharmaceuticals
DE69933208D1 (en) USE OF COMPOSITIONS WITH ANTISEPTICA AND / OR WOUND HEALING EFFECTS FOR THE DEEP BREATHING WAY
ATE310508T1 (en) DOSAGE FORM CONTAINING THERAPEUTIC FORMULATION
PT1117386E (en) ENTERIC AND COLONY ADMINISTRATION USING HPMC CAPSULES
HK1060045A1 (en) Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleepdisturbances
MY102459A (en) Oral sustained release pharmaceutical preparation.
IS1694B (en) Medicinal product for administration to oral animals containing proton pump blockers
HK1031197A1 (en) Osmotic dosage form comprising first and second coats
ATE227136T1 (en) AGENTS FOR ENHANCED ABSORPTION OF POLAR MEDICINAL SUBSTANCES FROM THE COLON
ATE211907T1 (en) OSMOTIC DRUG RELEASE SYSTEM
TR199701584T1 (en) New pharmaceutical composition with anesthetic effect
HUP0101293A2 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
SE9401406D0 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE248589T1 (en) MATRIX FOR THE CONTROLLED RELEASE OF MEDICINAL SUBSTANCES
EE03513B1 (en) New combinations of active substances containing clopidogrel and an antithrombotic compound
DE69209323D1 (en) MULTI-LAYER TABLETS WITH CONTROLLED DELIVERY OF ACTIVE SUBSTANCES CONTAINING BOTH NAPROXES AND NAPROXIC SODIUM SALT
ATE211649T1 (en) CONTROLLED RELEASE DOSE FORM FOR POTASSIUM
EE200100007A (en) Quinoline Derivatives, Their Use as Medicaments, Pharmaceutical Compositions Containing Them, and Use of Compounds and Pharmaceutical Compositions in the Treatment of Diseases Due to Pathological Inflammation and Autoimmunity
TR200101633T2 (en) Pharmaceutical composition
RU95101385A (en) Products containing g-csf and tnf-binding protein
KR20000001522A (en) Charcoal capsulated or tabletted health keeping medicine
GEP20043254B (en) Use of Camptothecin Derivatives with Reduced Gastrointestinal Toxicity
BR9912533A (en) Pharmaceutical composition having improved taste
ATE256134T1 (en) SULFATED PHOSPHATIDYLINOSITOLS, THEIR PRODUCTION AND USE

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination